Buscar
Mostrando ítems 1-10 de 19
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.
(Lippincott, Williams & Wilkins, 2019)
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.
(Lippincott, Williams & Wilkins, 2005)
Efecto sobre la función renal de régimen de tratamiento antirretroviral altamente activo que contiene lopinavir/ritonavir más tenofovir en pacientes con VIH-sida
(2009-08-13)
RESUMEN: El síndrome de inmunodeficiencia humana (SIDA) fue reportado hace 27 años. Para diciembre del 2006 se estimó que 22.5 millones de personas habían fallecido de esta enfermedad. Actualmente se estima que alrededor ...
SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial
Background: The antiviral effects of Novaferon, a potent antiviral protein drug, on COVID-19 was
evaluated in the laboratory, and in a randomized, open-label, parallel-group trial.
Methods: In the laboratory, Novaferon's ...
Guías de tratamiento para los pacientes infectados con COVID-19
(Colegio de Medicina Interna de México, 2021)
BACKGROUND: New information for potential treatments against SARS-CoV-2 is rapidly increasing. As a result, countries and organizations have begun to release therapeutic guidelines. OBJECTIVE: To provide a synopsis of the ...
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results
(Massachusetts Medical Society, 2020)
BACKGROUND: World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a - in patients hospitalized with ...
A Randomized Controlled Trial to Assess Safety, Tolerability, and Antepartum Viral Load with Increased Lopinavir/Ritonavir Dosage in Pregnancy
(Mary Ann Liebert, Inc, 2013-11-01)
HIV mother-to-child transmission (MTCT) is significantly reduced if antepartum viral load (apVL) is<50 copies/mL. Pharmacokinetic studies suggest increasing the dosage of lopinavir/ritonavir (LPV/r) in pregnancy. It is ...
Factors associated with clinical, immunological and virological responses in protease-inhibitor-experienced brazilian children receiving highly active antiretroviral therapy containing Lopinavir-Ritonavir
(Brazilian Society of Infectious Diseases, 2007-02-01)
This study evaluates clinical, virological and immunological responses to antiretroviral (ARV) therapy based on Lopinavir/ritonovir (LPV/r) in previously protease -inhibitor-experienced children. The study included 29 ...